nach oben

Erschienen in:

23.04.2016 | Review

Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations

verfasst von: Jeanne Murphy, Mark E. Sherman, Eva P. Browne, Ana I. Caballero, Elizabeth C. Punska, Ruth M. Pfeiffer, Hannah P. Yang, Maxwell Lee, Howard Yang, Gretchen L. Gierach, Kathleen F. Arcaro

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

This review summarizes methods related to the study of human breastmilk in etiologic and biomarkers research. Despite the importance of reproductive factors in breast carcinogenesis, factors that act early in life are difficult to study because young women rarely require breast imaging or biopsy, and analysis of critical circulating factors (e.g., hormones) is often complicated by the requirement to accurately account for menstrual cycle date. Accordingly, novel approaches are needed to understand how events such as pregnancy, breastfeeding, weaning, and post-weaning breast remodeling influence breast cancer risk. Analysis of breastmilk offers opportunities to understand mechanisms related to carcinogenesis in the breast, and to identify risk markers that may inform efforts to identify high-risk women early in the carcinogenic process. In addition, analysis of breastmilk could have value in early detection or diagnosis of breast cancer. In this article, we describe the potential for using breastmilk to characterize the microenvironment of the lactating breast with the goal of advancing research on risk assessment, prevention, and detection of breast cancer.

Nur mit Berechtigung zugänglich

Anderson KN, Schwab RB, Martinez ME (2014) Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 144(1):1–10. doi:10.1007/s10549-014-2852-7 CrossRefPubMedPubMedCentral

Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME (2014) How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst 106(8):dju165. doi:10.1093/jnci/dju165 CrossRefPubMedPubMedCentral

Palmer JR, Viscidi E, Troester MA, Hong CC, Schedin P, Bethea TN, Bandera EV, Borges V, McKinnon C, Haiman CA, Lunetta K, Kolonel LN, Rosenberg L, Olshan AF, Ambrosone CB (2014) Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. J Natl Cancer Inst 106(10):dju237. doi:10.1093/jnci/dju237 CrossRefPubMedPubMedCentral

Haricharan S, Dong J, Hein S, Reddy JP, Du Z, Toneff M, Holloway K, Hilsenbeck SG, Huang S, Atkinson R, Woodward W, Jindal S, Borges VF, Gutierrez C, Zhang H, Schedin PJ, Osborne CK, Tweardy DJ, Li Y (2013) Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy. Elife 2:e00996. doi:10.7554/eLife.00996 CrossRefPubMedPubMedCentral

Meier-Abt F, Bentires-Alj M, Rochlitz C (2015) Breast cancer prevention: lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection. Cancer Res 75(5):803–807. doi:10.1158/0008-5472.can-14-2717 CrossRefPubMed

Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, Yang XR, Papathomas D, Visscher D, Mies C, Degnim AC, Anderson WF, Hewitt S, Khodr ZG, Clare SE, Storniolo AM, Sherman ME (2014) Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst 106(10):dju286. doi:10.1093/jnci/dju286 CrossRefPubMedPubMedCentral

Russo J, Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11(4):169–178PubMed

Merrill RM, Fugal S, Novilla LB, Raphael MC (2005) Cancer risk associated with early and late maternal age at first birth. Gynecol Oncol 96(3):583–593. doi:10.1016/j.ygyno.2004.11.038 CrossRefPubMed

Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van ‘t Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Mulligan AM, O’Malley FP, Weerasooriya N, John EM, Beckmann MW, Hartmann A, Weihbrecht SB, Wachter DL, Jud SM, Loehberg CR, Baglietto L, English DR, Giles GG, McLean CA, Severi G, Lambrechts D, Vandorpe T, Weltens C, Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, Dork T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Perez JI, Menendez Rodriguez P, Zamora P, Benitez J, Ko YD, Fischer HP, Hamann U, Pesch B, Bruning T, Justenhoven C, Brauch H, Eccles DM, Tapper WJ, Gerty SM, Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Lindblom A, Margolin S, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gorski B, Gronwald J, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Kriege M, Tilanus-Linthorst MM, Collee M, Wang-Gohrke S, Pylkas K, Jukkola-Vuorinen A, Mononen K, Grip M, Hirvikoski P, Winqvist R, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Auvinen P, Soini Y, Sironen R, Bojesen SE, Orsted DD, Kaur-Knudsen D, Flyger H, Nordestgaard BG, Holland H, Chenevix-Trench G, Manoukian S, Barile M, Radice P, Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gaborieau V, Devilee P, Huijts PE, Tollenaar RA, Seynaeve C, Dite GS, Apicella C, Hopper JL, Hammet F, Tsimiklis H, Smith LD, Southey MC, Humphreys MK, Easton D, Pharoah P, Sherman ME, Garcia-Closas M (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103(3):250–263. doi:10.1093/jnci/djq526 CrossRefPubMedPubMedCentral

10.

Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE (2010) Control of mammary stem cell function by steroid hormone signalling. Nature 465(7299):798–802. doi:10.1038/nature09027 CrossRefPubMed

11.

Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K (2013) Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell 13(1):117–130. doi:10.1016/j.stem.2013.05.004 CrossRefPubMedPubMedCentral

12.

Pang WW, Hartmann PE (2007) Initiation of human lactation: secretory differentiation and secretory activation. J Mammary Gland Biol Neoplasia 12(4):211–221. doi:10.1007/s10911-007-9054-4 CrossRefPubMed

13.

Saint L, Smith M, Hartmann PE (1984) The yield and nutrient content of colostrum and milk of women from giving birth to 1 month post-partum. Br J Nutr 52(1):87–95CrossRefPubMed

14.

Hassiotou F, Geddes D (2013) Anatomy of the human mammary gland: current status of knowledge. Clin Anat 26(1):29–48. doi:10.1002/ca.22165 CrossRefPubMed

15.

McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, Schedin P (2006) Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol 168(2):608–620. doi:10.2353/ajpath.2006.050677 CrossRefPubMedPubMedCentral

16.

O’Brien J, Hansen K, Barkan D, Green J, Schedin P, O’Brien J, Hansen K, Barkan D, Green J, Schedin P (2011) Non-steroidal anti-inflammatory drugs target the pro-tumorigenic extracellular matrix of the postpartum mammary gland. Int J Dev Biol 55(7–9):745–755. doi:10.1387/ijdb.113379jo CrossRefPubMed

17.

Martinson HA, Jindal S, Durand-Rougely C, Borges VF, Schedin P (2015) Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression. Int J Cancer 136(8):1803–1813. doi:10.1002/ijc.29181 CrossRefPubMedPubMedCentral

18.

Browne EP, Punska EC, Lenington S, Otis CN, Anderton DL, Arcaro KF (2011) Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics 6(12):1425–1435. doi:10.4161/epi.6.12.18280 CrossRefPubMed

19.

Lemay DG, Hovey RC, Hartono SR, Hinde K, Smilowitz JT, Ventimiglia F, Schmidt KA, Lee JW, Islas-Trejo A, Silva PI, Korf I, Medrano JF, Barry PA, German JB (2013) Sequencing the transcriptome of milk production: milk trumps mammary tissue. BMC Genom 14:872. doi:10.1186/1471-2164-14-872 CrossRef

20.

Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ (2006) Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 97(2):191–197. doi:10.1007/s10549-005-9111-x CrossRefPubMed

21.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS (2000) Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 92(15):1217–1227CrossRefPubMed

22.

Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gong Y, Browne D, Hortobagyi GN, Sneige N (2007) Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 13(16):4943–4948. doi:10.1158/1078-0432.ccr-06-2732 CrossRefPubMed

23.

Patil DB, Lankes HA, Nayar R, Masood S, Bryk M, Hou N, Rademaker A, Khan SA (2008) Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res Treat 112(2):327–333. doi:10.1007/s10549-007-9861-8 CrossRefPubMed

24.

Hoffman A, Pellenberg R, Drendall CI, Seewaldt V (2012) Comparison of random periareolar fine needle aspirate versus ductal lavage for risk assessment and prevention of breast cancer. Curr Breast Cancer Rep 4(3):180–187. doi:10.1007/s12609-012-0081-9 CrossRefPubMedPubMedCentral

25.

Wong CM, Anderton DL, Smith-Schneider S, Wing MA, Greven MC, Arcaro KF (2010) Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics 5(7):645–655. doi:10.4161/epi.5.7.12961 CrossRefPubMedPubMedCentral

26.

Grosvenor CE, Picciano MF, Baumrucker CR (1993) Hormones and growth factors in milk. Endocr Rev 14(6):710–728. doi:10.1210/edrv-14-6-710 CrossRefPubMed

27.

Yang HP, Schneider SS, Chisholm CM, Browne EP, Mahmood S, Gierach GL, Lenington S, Anderton DL, Sherman ME, Arcaro KF (2015) Association of TGF-beta2 levels in breast milk with severity of breast biopsy diagnosis. Cancer Causes Control 26(3):345–354. doi:10.1007/s10552-014-0498-8 CrossRefPubMedPubMedCentral

28.

Froehlich JW, Dodds ED, Barboza M, McJimpsey EL, Seipert RR, Francis J, An HJ, Freeman S, German JB, Lebrilla CB (2010) Glycoprotein expression in human milk during lactation. J Agric Food Chem 58(10):6440–6448. doi:10.1021/jf100112x CrossRefPubMedPubMedCentral

29.

Reiner JL, Wong CM, Arcaro KF, Kannan K (2007) Synthetic musk fragrances in human milk from the United States. Environ Sci Technol 41(11):3815–3820CrossRefPubMed

30.

Zimmers SM, Browne EP, O’Keefe PW, Anderton DL, Kramer L, Reckhow DA, Arcaro KF (2014) Determination of free Bisphenol A (BPA) concentrations in breast milk of U.S. women using a sensitive LC/MS/MS method. Chemosphere 104:237–243. doi:10.1016/j.chemosphere.2013.12.085 CrossRefPubMed

31.

Bergmann H, Rodriguez JM, Salminen S, Szajewska H (2014) Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop report. Br J Nutr 112(7):1119–1128. doi:10.1017/s0007114514001949 CrossRefPubMed

32.

Hawkes JS, Bryan DL, Gibson RA (2002) Cytokine production by human milk cells and peripheral blood mononuclear cells from the same mothers. J Clin Immunol 22(6):338–344CrossRefPubMed

33.

Hines EP, Rayner JL, Barbee R, Moreland RA, Valcour A, Schmid JE, Fenton SE (2007) Assays for endogenous components of human milk: comparison of fresh and frozen samples and corresponding analytes in serum. J Hum Lact 23(2):144–156. doi:10.1177/0890334407300334 CrossRefPubMed

34.

Ozarda Y, Gunes Y, Tuncer GO (2012) The concentration of adiponectin in breast milk is related to maternal hormonal and inflammatory status during 6 months of lactation. Clin Chem Lab Med 50(5):911–917. doi:10.1515/cclm-2011-0724 CrossRefPubMed

35.

Chollet-Hinton LS, Stuebe AM, Casbas-Hernandez P, Chetwynd E, Troester MA (2014) Temporal trends in the inflammatory cytokine profile of human breastmilk. Breastfeed Med 9(10):530–537. doi:10.1089/bfm.2014.0043 CrossRefPubMedPubMedCentral

36.

Zhang L, de Waard M, Verheijen H, Boeren S, Hageman JA, van Hooijdonk T, Vervoort J, van Goudoever JB, Hettinga K (2016) Changes over lactation in breast milk serum proteins involved in the maturation of immune and digestive system of the infant. J Proteom. doi:10.1016/j.jprot.2016.02.005

37.

Baumgartel KL, Conley YP (2013) The utility of breastmilk for genetic or genomic studies: a systematic review. Breastfeed Med 8(3):249–256. doi:10.1089/bfm.2012.0054 CrossRefPubMedPubMedCentral

38.

Ballard O, Morrow AL (2013) Human milk composition: nutrients and bioactive factors. Pediatr Clin N Am 60(1):49–74. doi:10.1016/j.pcl.2012.10.002 CrossRef

39.

Andreas NJ, Kampmann B, Mehring Le-Doare K (2015) Human breast milk: A review on its composition and bioactivity. Early Hum Dev 91(11):629–635. doi:10.1016/j.earlhumdev.2015.08.013 CrossRefPubMed

40.

Agarwal S, Karmaus W, Davis S, Gangur V (2011) Immune markers in breast milk and fetal and maternal body fluids: a systematic review of perinatal concentrations. J Hum Lact 27(2):171–186CrossRefPubMed

41.

Browne EP, Dinc SE, Punska EC, Agus S, Vitrinel A, Erdag GC, Anderton DL, Arcaro KF, Yilmaz B (2014) Promoter methylation in epithelial-enriched and epithelial-depleted cell populations isolated from breast milk. J Hum Lact 30(4):450–457. doi:10.1177/0890334414548224 CrossRefPubMed

42.

Morton J, Wong RJ, Hall JY, Pang WW, Lai CT, Lui J, Hartmann PE, Rhine WD (2012) Combining hand techniques with electric pumping increases the caloric content of milk in mothers of preterm infants. J Perinatol 32(10):791–796. doi:10.1038/jp.2011.195 CrossRefPubMed

43.

Shabb NS, Boulos FI, Abdul-Karim FW (2013) Indeterminate and erroneous fine-needle aspirates of breast with focus on the ‘true gray zone’: a review. Acta Cytol 57(4):316–331. doi:10.1159/000351159 CrossRefPubMed

44.

Macmahon B, Trichopoulos D, Ing R, Ho JHC, Petrakis N (1977) Unilateral suckling and breast cancer. Lancet 310(8039):655–657CrossRef

45.

Veltmaat JM, Ramsdell AF, Sterneck E (2013) Positional variations in mammary gland development and cancer. J Mammary Gland Biol Neoplasia 18(2):179–188. doi:10.1007/s10911-013-9287-3 CrossRefPubMedPubMedCentral

46.

Saarela T, Kokkonen J, Koivisto M (2005) Macronutrient and energy contents of human milk fractions during the first six months of lactation. Acta Paediatr 94(9):1176–1181. doi:10.1080/08035250510036499 CrossRefPubMed

47.

Hassiotou F, Hepworth AR, Williams TM, Twigger AJ, Perrella S, Lai CT, Filgueira L, Geddes DT, Hartmann PE (2013) Breastmilk cell and fat contents respond similarly to removal of breastmilk by the infant. PLoS ONE 8(11):e78232. doi:10.1371/journal.pone.0078232 CrossRefPubMedPubMedCentral

48.

Innis SM (2014) Impact of maternal diet on human milk composition and neurological development of infants. Am J Clin Nutr 99(3):734S–741S. doi:10.3945/ajcn.113.072595 CrossRefPubMed

49.

Lawrence RA (1999) Storage of human milk and the influence of procedures on immunological components of human milk. Acta Paediatr Supplement 88(430):14–18CrossRef

50.

Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N, Ainsworth P, Senter L, Eisen A, Eng C, Singer C, Ginsburg O, Blum J, Huzarski T, Poll A, Sun P, Narod SA (2012) Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 14(2):R42. doi:10.1186/bcr3138 CrossRefPubMedPubMedCentral

51.

Kamran SC, Berrington de Gonzalez A, Ng A, Haas-Kogan D, Viswanathan AN (2016) Therapeutic radiation and the potential risk of second malignancies. Cancer. doi:10.1002/cncr.29841 PubMed

52.

Ronckers CM, Erdmann CA, Land CE (2005) Radiation and breast cancer: a review of current evidence. Breast Cancer Res 7(1):21–32. doi:10.1186/bcr970 CrossRefPubMedPubMedCentral

53.

Lyons TR, O’Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17(9):1109–1115. doi:10.1038/nm.2416 CrossRefPubMedPubMedCentral

54.

Konishi Y, Kakimoto K, Nagayoshi H, Nakano T (2016) Trends in the enantiomeric composition of polychlorinated biphenyl atropisomers in human breast milk. Environ Sci Pollut Res Int 23(3):2027–2032. doi:10.1007/s11356-015-4620-6 CrossRefPubMed

55.

Geraghty SR, Davidson BS, Warner BB, Sapsford AL, Ballard JL, List BA, Akers R, Morrow AL (2005) The development of a research human milk bank. J Hum Lact 21(1):59–66. doi:10.1177/0890334404273162 CrossRefPubMed

56.

Human Milk Banks (2003) Centers for Disease Control and Prevention. http://www.web.archive.org/web/20050204055446/ http://www.cdc.gov/breastfeeding/compend-milkbanks.htm. Accessed 4 Jan 2015

57.

Sherman ME, Figueroa JD, Henry JE, Clare SE, Rufenbarger C, Storniolo AM (2012) The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the “molecular histology” of the breast. Cancer Prev Res 5(4):528–535. doi:10.1158/1940-6207.capr-11-0234 CrossRef

58.

Kirmeyer SE, Hamilton BE (2011) Transitions between childlessness and first birth: three generations of U.S. women. Vital and health statistics series 2. Data Eval Methods Res 153:1–18

59.

Worldbank (2016) Fertility rate, total (births per woman). http://data.worldbank.org/indicator/SP.DYN.TFRT.IN. Accessed 12 March 2016

60.

Victora CG, Bahl R, Barros AJ, Franca GV, Horton S, Krasevec J, Murch S, Sankar MJ, Walker N, Rollins NC (2016) Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387(10017):475–490. doi:10.1016/s0140-6736(15)01024-7 CrossRefPubMed

61.

HP (2015) Maternal, Infant and Child Health. Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. http://www.healthypeople.gov/2020/topics-objectives/topic/maternal-infant-and-child-health/objectives

62.

Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, Boffetta P, Weiss M (2015) Breastfeeding and breast cancer risk by receptor status–a systematic review and meta-analysis. Ann Oncol 26(12):2398–2407. doi:10.1093/annonc/mdv379 PubMed

Titel: Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations
verfasst von: Jeanne Murphy
Mark E. Sherman
Eva P. Browne
Ana I. Caballero
Elizabeth C. Punska
Ruth M. Pfeiffer
Hannah P. Yang
Maxwell Lee
Howard Yang
Gretchen L. Gierach
Kathleen F. Arcaro
Publikationsdatum: 23.04.2016
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 1/2016
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-016-3796-x

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer

Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis

Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study

Apparent diffusion coefficient of breast cancer and normal fibroglandular tissue in diffusion-weighted imaging: the effects of menstrual cycle and menopausal status

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie